Inborn errors of metabolism in 174 cases of cerebral palsy

Authors

  • Jesús Manuel Rodríguez R
  • Jadwiga Sánchez

Keywords:

inborn errors of metabolism, cerebral palsy, genetic.

Abstract

Introduction: Cerebral Palsy (CP) is a set of non-progressive motor alterations in the child and youth population, caused by injury - at the brain level - of neurons or fibers of that pathway, their afferences or those that modulate it; for its diagnosis, other pathologies that are also frequent and that can simultaneously or causally affect the motor skills of the same patient must be known; The result would be both voluntary and involuntary motor dysfunction, reflected or with purpose, of posture and / or muscle tone. Objective: to detect inborn metabolic errors (EIM) that cause or are associated with CP in a significant series. Methods: Descriptive-interpretive study, we reviewed the clinical records of the Cerebral Palsy Center of Caracas, in whose diagnoses both alterations were presented, between the years 1988 and 2018. Results: Of the 2,000 clinical histories reviewed, the clinical examination and tests Laboratory tests allowed the selection of 174 cases of IMD. Conclusions: Inborn metabolic errors were typified in ten different clinical forms, they were evidenced in patients with CP treated in a public center in Caracas, it is possible that the casuistry is several times greater in Venezuela since the investigation is no longer applied in the centers of public attention.

Downloads

Download data is not yet available.

References

Barkudah E, Glader L. Cerebral palsy: Epidemiology, etiology and prevention. https://www.uptodate.com/contents/search. Accessed July 10, 2019.

Ali A, Yalçın R, Ünlüer-Gümüştaş A. Cranial MR characteristics of Cerebral Palsy cases and correlation of findings with clinical results. Turk J Pediatr. 2019; 61(4): 525-537.

Stadskleiv K. Cognitive functioning in children with cerebral palsy. Dev Med Child Neurol. 2020 Mar; 62(3): 283-289.

Lemeshko V. Mitocondrias normales. El papel de la membrana mitocondrial externa en el control del metabolismo energético celular. Rev Acad Colomb Cienc Ex Fis Nat Enero-marzo 2018; 42(162): 6-21.

Rebecca V, Nicastri M, McLaughlin N, Fennelly C, McAfee Q, Roughe A, et al. A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles. Cancer Discov 2017; 7(11): 1266-1283. doi: 10.1158/2159-8290.CD-17-0741. Epub 2017 Sep 12

Garcia G. Los peroxisomas y su importancia biomédica. Rev Medic Sanitas 2019; 12 (2): 30-40.

D’Ortencio A, Navigante A. Disfunción mitocondrial y enfermedades cardiovasculares. Insuf Card 2016; 11 (4): 201-214.

Rua M. Enfermedades metabólicas lisosomales. Manifestaciones osteoarticulares. Protoc Diagn Ter Pediatr 2014; (1): 231-239.

Coutinho M. Molecular, biochemical and functional study in genes determining missorting of lysosomal proteins. ProQuest LLC, Ann Arbor, MI. (2017). P. 1-3.

Rosewich H, Waterham H, Tien B, Ohlenbusch A, Gärtner J. Clinical utility gene card for Zellweger syndrome Spectrum. European Journal of Human Genetics. 2015; 23. doi:10.1038/ejhg.2014.250; published online 19 November 2014.

Cabello J, Giugliani R. Errores innatos del metabolismo. Rev Med Clin Las Condes 2015; 26(4): 483-486.

López L, Gutiérrez L. Tratamiento de las enfermedades lisosomales en la población pediátrica. Anals Ped Contin 2013; 11(3): 159-161.

Mattman A, Potter M. Approach to the interpretation of unexpected laboratory results, arising in the care of patients with inborn errors of metabolism (IEM). Rev Endocr Metab Disord 2018 Mar; 19(1):5-12.

Sanjurjo P, Baldellou A, Aldámiz K, Montejo M, García M. Los errores congénitos del metabolismo como enfermedades raras con un planteamiento global específico. Anales Sis San Navarra 2008; 31(Suppl 2): 55-73.

Kleinsteuber K, Avaria M, Varela X. Parálisis cerebral. Rev Ped Electrón 2014; 11(2): 54-70.

Cabello J, Giugliani R. Errores innatos del metabolismo. Rev Med Clin Las Condes. 2015/07/01 doi10.1016/j.rmclc.2015.06.022

Rejingoud DJ. Flux analysis of inborn errors of metabolism. J Inherit Metabolism Dis 2018; 41(3): 309-28.

Campistol J. Orientación diagnóstica de los errores congénitos del metabolismo a partir de la neuroimagen. Pediatr Panamá 2017; 46 (2): 87-92.

Ruiz Pons M, Sánchez-Valverde F, Dalmau Serra J, Gómez L. Tratamiento nutricional de los errores innatos del metabolismo. 2a ed. Madrid Drug Farma 2017. Pp. 22-29.

Forero E, Echeverri O, Espinosa E, Guevara J, Barrera L. Acidemia glutárica tipo 1: presentación de un caso y revisión de la literatura. Iatreia. 2015 Abr-Jun;28(2):193-197. DOI 10.17533/udea.iatreia.v28n2a09.

Dominguez C, Martin M. Miopatías metabólicas, mitocondriales y tóxicas. Medicine 2019; 12(76): 4497-4506.

Pallarés M, Díaz M, Cervino J, Ripoll E, Martínez M. Acidosis láctica en pediatría. Quím Clín 2002; 21 (4): 280-284.

Brown G. Pyruvate dehydrogenase deficiency and the brain. Dev Med Child Neurol 2012; 54: 395-396.

Manoli I, Sloan J, Venditti C. Isolated Methylmalonic Acidemia. Gene Reviews. Dec 1, 2016; https://www.ncbi.nlm.nih.gov/books/NBK1231/. Accessed 1/21/2020.

Mora L, Suárez F. Aproximación diagnóstica de los errores innatos del metabolismo en la unidad de cuidado intensivo neonatal: acidosis metabólica, hiperamonemia e hipoglicemia. Revista Biosalud 2017; 16(2): 83-95 DOI: 10.17151/biosa.2017.16.2.8

Kontoangelos K, Lazaratou H, Economou M, Dikeos D, Papageorgiou C. Acute Psychotic Syndrome in a Male Adolescent with Succinic Semialdehyde Dehydrogenase Deficiency. Psychiatry Investig. 2019 Feb; 16(2): 172–173.

Mato S, Queiro V, Merino A, López M. Cribado neonatal del déficit de biotinidasa. Red Española de Agencias de Evaluación de Tecnologías y Prestaciones del SNS. Agencia de Evaluación de Tecnologías Sanitarias de Galicia; 2014.

Martins J, Teixeira M, Cardoso M, Lima P, Briones C. Galactosemia: genotipo y fenotipo de siete pacientes. Rev Neurol 2004; 38(12):1132-1135.

Spencer L, Bubner T, Bain E, Middleton P. Screening and subsequent management for thyroid dysfunction pre‐pregnancy and during pregnancy for improving maternal and infant health. Cochrane Database of Systematic Reviews 2015; 9: CD011263. DOI: 10.1002/14651858.CD011263.pub2.

Sanchez A, Martínez L, Arteaga G, Torres R, Marroquín A, Abrego V, et al. Secuelas neurológicas en tres pacientes con fenilcetonuria clásica diagnosticada tardíamente. Bol. Med. Hosp. Infant. Mex. [online]. 2008; 65(3): 191-195.

How to Cite

Rodríguez R, J. M., & Sánchez, J. (2020). Inborn errors of metabolism in 174 cases of cerebral palsy. Revista Digital De Postgrado, 9(2), e205. Retrieved from http://saber.ucv.ve/ojs/index.php/rev_dp/article/view/18928